Abstract Coronavirus disease-2019 (COVID-19) caused by SARS-CoV-2 is an ongoing viral
pandemic marked by increased risk of thrombotic events. However, the role of platelets in …

There is an urgent need to understand the underlying mechanisms contributing to
thrombotic and inflammatory complications during COVID‐19. Data from independent …

Since the onset of the global pandemic of coronavirus disease 2019 (COVID‐19), there is an
urgent need to understand the pathogenesis of the common inflammatory and thrombotic …

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is an ongoing viral
pandemic marked by increased risk of thrombotic events. However, the role of platelets in …

The SARS-CoV-2 virus, causing the devastating COVID-19 pandemic, has been reported to
affect platelets and cause increased thrombotic events, hinting at the possible bidirectional …

Platelets may be a target of bacteria and viruses, which can directly or indirectly activate
them so promoting thrombosis. In accordance with this, community-acquired pneumonia …

Rationale: In addition to the overwhelming lung inflammation that prevails in coronavirus
disease 2019 (COVID-19), hypercoagulation and thrombosis contribute to the lethality of …

Background Critically ill patients diagnosed with COVID-19 may develop a pro-thrombotic
state that places them at a dramatically increased lethal risk. Although platelet activation is …

Evidence suggests that platelets may directly interact with SARS-CoV-2, raising the concern
whether ACE2 receptor plays a role in this interaction. The current study showed that SARS …

Abstract Novel coronavirus disease 2019 (COVID-19) is associated with a hypercoagulable
state, characterized by abnormal coagulation parameters and by increased incidence of …